Immune Profiling in Patients with High-Risk Smoldering Myeloma

Request Access

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.

Romanos Sklavenitis-Pistofidis, Michelle P. Aranha, R. Redd, et al.. (2022). Cancer cell. Cited 38 times. https://doi.org/10.1016/j.ccell.2022.10.017
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747